Harbour Island Acquisition Corp. I Announces the Pricing of $100,000,000 Initial Public Offering
PR Newswire
Today at 9:00pm UTC
THOR INDUSTRIES ANNOUNCES INCREASED REGULAR QUARTERLY DIVIDEND
PR Newswire
Today at 8:45pm UTC
Bybit Expands Beyond Crypto as CEO Outlines Next Phase of Financial Platform
NewsDirect
Today at 8:33pm UTC
ATI Announces Webcast for Third Quarter 2026 Results
PR Newswire
Today at 8:31pm UTC
Hycroft Drills New Best Hole Ever
PR Newswire
Today at 8:30pm UTC
DuPont Announces Regular Quarterly Dividend on Common Stock
PR Newswire
Today at 8:30pm UTC
High Winds, Dry Conditions Mean PG&E May Need to Proactively Turn Off Power for Safety Wednesday Evening in Portions of Twenty-Nine...
PR Newswire
Today at 8:30pm UTC
Meet A7 International, an Innovative Global Platform Designed to Reinvent the International Payments Market
NewsDirect
Today at 8:19pm UTC
Rocket One Signs Agreement to Advance Nanomagnetic AI Chip Technology and Device Prototyping
PR Newswire
Today at 8:16pm UTC
AT&T to Sell AT&T Mexico to Grupo Televisa and Fintech Holdings
PR Newswire
Today at 8:15pm UTC
TriNet Expands Embedded HR Solutions and AI Capabilities for Small and Medium-Size Businesses
PR Newswire
Today at 8:15pm UTC
Galaxy Schedules Webcast and Investor Call to Review Third Quarter 2026 Results on October 27, 2026
PR Newswire
Today at 8:15pm UTC
The Andersons, Inc. to Release Third Quarter Results on November 3
PR Newswire
Today at 8:05pm UTC
YYForce Brings Humanoid Robots to Hospitality in Landmark Partnership with Novotel & Mercure Singapore on Stevens
PR Newswire
Today at 8:05pm UTC
Realty Income Announces 676th Consecutive Common Stock Monthly Dividend
PR Newswire
Today at 8:05pm UTC
10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026
PR Newswire
Today at 8:05pm UTC
Ribbon Communications to Report Third Quarter 2026 Financial Results on October 27, 2026
PR Newswire
Today at 8:03pm UTC
Inhibrx Announces Participation in Upcoming Scientific Conferences
PR Newswire
Today at 8:00pm UTC
AbbVie Presents New Phase 3 AFFIRM Data Showing Clinical and Endoscopic Outcomes With Subcutaneous SKYRIZI® (risankizumab-rzaa) in Patients...
PR Newswire
Today at 7:15pm UTC
Franco-Nevada to Release Third Quarter 2026 Results
PR Newswire
Today at 7:15pm UTC